Ipsen Sa ADR (IPSEY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IPSEY | UTHR | SMMT | ||
| Company | Ipsen Sa ADR | United Therapeutic | Summit Therapeu ADR | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 48.0000 | 596.88 | 19.17 | ||
| High | 48.2100 | 597.00 | 19.59 | ||
| Low | 48.0000 | 570.22 | 18.57 | ||
| Latest | 48.2100 | 570.27 | 18.92 | ||
| Change | +1.9100 | -22.71 | -0.04 | ||
| % Change | +4.13% | -3.83% | -0.21% | ||
| Volume | 400 | 755,000 | 2,375,100 | ||
| 20-Day Average Volume | 1,805 | 723,605 | 2,646,215 | ||
| Previous Close | 46.3000 | 592.98 | 18.96 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 44.0096 | 534.97 | 16.32 | ||
| 20-Day Raw Stochastic | 100.00% | 72.46% | 86.57% | ||
| 20-Day Relative Strength | 67.14 | 61.12 | 62.56 | ||
| Weighted Alpha | +77.74 | +84.16 | +16.06 | ||
| Today's Opinion | 100% Buy | 100% Buy | 8% Sell | ||
| Previous Opinion | 100% Buy | 100% Buy | 8% Sell | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.13% since 03/17/26 | +5.29% since 03/25/26 | +5.46% since 03/25/26 | ||
| Low | 43.0900 on 03/23/26 | 520.97 on 03/27/26 | 16.38 on 03/27/26 | ||
| High | 48.2100 on 04/01/26 | 607.89 on 03/30/26 | 19.59 on 04/01/26 | ||
| 1-Month | |||||
| %Chg | +0.84% since 02/25/26 | +13.17% since 02/27/26 | +14.04% since 02/27/26 | ||
| Low | 43.0900 on 03/23/26 | 471.29 on 03/06/26 | 14.60 on 03/06/26 | ||
| High | 48.2100 on 04/01/26 | 607.89 on 03/30/26 | 19.59 on 04/01/26 | ||
| 3-Month | |||||
| %Chg | +32.59% since 12/31/25 | +17.04% since 12/31/25 | +8.18% since 12/31/25 | ||
| Low | 34.3400 on 01/05/26 | 455.63 on 01/20/26 | 13.83 on 02/05/26 | ||
| High | 48.2100 on 04/01/26 | 607.89 on 03/30/26 | 20.20 on 01/09/26 | ||
| 6-Month | |||||
| %Chg | +45.21% since 09/29/25 | +30.15% since 10/01/25 | -7.66% since 10/01/25 | ||
| Low | 32.6800 on 10/21/25 | 409.07 on 10/28/25 | 13.83 on 02/05/26 | ||
| High | 48.2100 on 04/01/26 | 607.89 on 03/30/26 | 25.49 on 10/13/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 15,522,445 | 25,989,122 | 14,701,071 | ||
| Shares Outstanding, K | 335,258 | 43,828 | 775,373 | ||
| Annual Sales | 4,445,500,000 | 3,182,700,000 | 0 | ||
| Annual Net Income | 501,780,000 | 1,334,700,000 | -1,079,590,000 | ||
| Last Quarter Sales | N/A | 790,200,000 | 0 | ||
| Last Quarter Net Income | N/A | 364,300,000 | -219,170,000 | ||
| 60-Month Beta | 0.47 | 0.84 | -1.43 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 7.70 on 02/25/26 | -0.29 on 02/23/26 | ||
| Latest Earnings Date | 02/12/26 | 04/29/26 | 05/07/26 | ||
| Most Recent Dividend | 0.259 on 06/09/25 | N/A | N/A | ||
| Next Ex-Dividends Date | 06/09/25 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.09 | 0.00 | ||